The administration of U.S. President Donald trump has signed with pharmaceutical company Phlow Corp contract manufacturing of generics and active pharmaceutical ingredients necessary for the country to treat patients with coronavirus infection. About it reports Reuters.
The transaction value amounted to 354 million dollars. In US government circles, this contract was called a historic event to return the production of drugs into the country.
Phlow Corp is a generic company based in Virginia, which currently manufactures drugs in factories in India and China, according to the NYT.